How this Seattle biotech startup survived the 'Valley of Death'

A summer project with a group of undergraduate students has turned into a stand-alone biotechnology company working to develop and commercialize a treatment for celiac disease. Ingrid Swanson Pultz co-founded PvP Biologics with two other UW researchers and spun the company out of the university in November. PvP now has an exclusive license to continue working on oral treatments for celiac disease, a genetic disorder that causes some people to react to gluten and can lead to serious damage to the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news